On December 1, Health Canada approved a single-use device (Humira Pen, made by Abbott Laboratories, Ltd) for administering adalimumab in the treatment of moderate to severe rheumatoid arthritis ...

The FDA has approved a class 3 medical device (Pill Swallowing Cup), a device for administering adalimumab (Humira Pen), and a safety syringe (SharpShield).

Anti- TNF drugs, such as Humira, block the action of this protein. The drugs normally have to be injected at a clinic once a fortnight, but the pen version of Humira was recently approved for use ...